ADIPOQ and polycystic ovary syndrome: As the characteristics of metabolic syndrome are associated with a number of reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus, preeclampsia, EMs, fetal growth restriction, and ovarian and endometrial cancers, their pathogenesis may be influenced by adiponectin (Barbe et al., 2019).